Cargando…

Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology

BACKGROUND: To evaluate in women with functional hypothalamic amenorrhea (FHA), whether there is a difference between patients with and without polycystic ovarian morphology (PCOM) concerning the response to a gonadotropin releasing hormone (GnRH) stimulation test and to pulsatile GnRH treatment. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hager, Marlene, Ott, Johannes, Marschalek, Julian, Marschalek, Marie-Louise, Kinsky, Clemens, Marculescu, Rodrig, Dewailly, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251918/
https://www.ncbi.nlm.nih.gov/pubmed/35787707
http://dx.doi.org/10.1186/s12958-022-00961-y
_version_ 1784740140686508032
author Hager, Marlene
Ott, Johannes
Marschalek, Julian
Marschalek, Marie-Louise
Kinsky, Clemens
Marculescu, Rodrig
Dewailly, Didier
author_facet Hager, Marlene
Ott, Johannes
Marschalek, Julian
Marschalek, Marie-Louise
Kinsky, Clemens
Marculescu, Rodrig
Dewailly, Didier
author_sort Hager, Marlene
collection PubMed
description BACKGROUND: To evaluate in women with functional hypothalamic amenorrhea (FHA), whether there is a difference between patients with and without polycystic ovarian morphology (PCOM) concerning the response to a gonadotropin releasing hormone (GnRH) stimulation test and to pulsatile GnRH treatment. METHODS: In a retrospective observational study, 64 women with FHA who underwent a GnRH stimulation test and 32 age-matched controls without PCOM were included. Pulsatile GnRH treatment was provided to 31 FHA patients and three-month follow-up data were available for 19 of these. RESULTS: Serum levels of gonadotropins and estradiol were lower in FHA women than in controls (p < 0.05). FHA patients revealed PCOM in 27/64 cases (42.2%). FHA patients without PCOM revealed lower anti-Müllerian hormone (AMH) levels than controls (median 2.03 ng/mL, IQR 1.40–2.50, versus 3.08 ng/mL, IQR 2.24–4.10, respectively, p < 0.001). Comparing FHA patients with and without PCOM, the latter revealed lower AMH levels, a lower median LH increase after the GnRH stimulation test (240.0%, IQR 186.4–370.0, versus 604.9%, IQR 360.0–1122.0; p < 0.001) as well as, contrary to patients with PCOM, a significant increase in AMH after three months of successful pulsatile GnRH treatment (median 1.69 ng/mL at baseline versus 2.02 ng/mL after three months of treatment; p = 0.002). CONCLUSIONS: In women with FHA without PCOM, the phenomenon of low AMH levels seems to be based on relative gonadotropin deficiency rather than diminished ovarian reserve. AMH tended to rise after three months of pulsatile GnRH treatment. The differences found between patients with and without PCOM suggest the former the existence of some PCOS-specific systemic and/or intra-ovarian abnormalities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12958-022-00961-y.
format Online
Article
Text
id pubmed-9251918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92519182022-07-05 Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology Hager, Marlene Ott, Johannes Marschalek, Julian Marschalek, Marie-Louise Kinsky, Clemens Marculescu, Rodrig Dewailly, Didier Reprod Biol Endocrinol Research BACKGROUND: To evaluate in women with functional hypothalamic amenorrhea (FHA), whether there is a difference between patients with and without polycystic ovarian morphology (PCOM) concerning the response to a gonadotropin releasing hormone (GnRH) stimulation test and to pulsatile GnRH treatment. METHODS: In a retrospective observational study, 64 women with FHA who underwent a GnRH stimulation test and 32 age-matched controls without PCOM were included. Pulsatile GnRH treatment was provided to 31 FHA patients and three-month follow-up data were available for 19 of these. RESULTS: Serum levels of gonadotropins and estradiol were lower in FHA women than in controls (p < 0.05). FHA patients revealed PCOM in 27/64 cases (42.2%). FHA patients without PCOM revealed lower anti-Müllerian hormone (AMH) levels than controls (median 2.03 ng/mL, IQR 1.40–2.50, versus 3.08 ng/mL, IQR 2.24–4.10, respectively, p < 0.001). Comparing FHA patients with and without PCOM, the latter revealed lower AMH levels, a lower median LH increase after the GnRH stimulation test (240.0%, IQR 186.4–370.0, versus 604.9%, IQR 360.0–1122.0; p < 0.001) as well as, contrary to patients with PCOM, a significant increase in AMH after three months of successful pulsatile GnRH treatment (median 1.69 ng/mL at baseline versus 2.02 ng/mL after three months of treatment; p = 0.002). CONCLUSIONS: In women with FHA without PCOM, the phenomenon of low AMH levels seems to be based on relative gonadotropin deficiency rather than diminished ovarian reserve. AMH tended to rise after three months of pulsatile GnRH treatment. The differences found between patients with and without PCOM suggest the former the existence of some PCOS-specific systemic and/or intra-ovarian abnormalities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12958-022-00961-y. BioMed Central 2022-07-04 /pmc/articles/PMC9251918/ /pubmed/35787707 http://dx.doi.org/10.1186/s12958-022-00961-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hager, Marlene
Ott, Johannes
Marschalek, Julian
Marschalek, Marie-Louise
Kinsky, Clemens
Marculescu, Rodrig
Dewailly, Didier
Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
title Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
title_full Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
title_fullStr Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
title_full_unstemmed Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
title_short Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
title_sort basal and dynamic relationships between serum anti-müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251918/
https://www.ncbi.nlm.nih.gov/pubmed/35787707
http://dx.doi.org/10.1186/s12958-022-00961-y
work_keys_str_mv AT hagermarlene basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology
AT ottjohannes basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology
AT marschalekjulian basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology
AT marschalekmarielouise basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology
AT kinskyclemens basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology
AT marculescurodrig basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology
AT dewaillydidier basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology